rethinkPeptides Search
Menu
Research citation

Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine.

Journal for immunotherapy of cancer, 13(7)

Citation

Koido, Shigeo; Taguchi, Junichi; Shimabuku, Masamori; Bito, Tuuse; Morimoto, Soyoko; Oji, Yusuke; Oka, Yoshihiro; Ito, Masaki; Shimizu, Yoko; Ito, Zensho; Uchiyama, Kan; Saruta, Masayuki; Sato, Nobuhiro; Ohkusa, Toshifumi; Shimodaira, Shigetaka; Sugiyama, Haruo. (2025). Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine.. Journal for immunotherapy of cancer, 13(7). https://doi.org/10.1136/jitc-2024-011426